Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19
Clinical trial NCT05271929 · TERMINATED
Trial details
- NCT number
- NCT05271929
- Sponsor
- Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2024-01-18
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.